Hyperion Defi, INC. (HYPD) — 8-K Filings

All 8-K filings from Hyperion Defi, INC.. Browse 50 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (50)

HYPERION DEFI Files 8-K: Financials, Bylaw Changes, Reg FD Disclosure — Mar 26, 2026
HYPERION DEFI, INC. filed an 8-K on March 26, 2026, reporting on Items 2.02 (Results of Operations and Financial Condition), 5.03 (Amendments to Articles of Inc
Hyperion Defi, Inc. Files 8-K Report — Dec 10, 2025 Risk: medium
On December 10, 2025, HYPERION DEFI, INC. (formerly EYENOVIA, INC.) filed an 8-K report. The filing indicates a change in the company's name and potentially oth
Hyperion DeFi Enters Material Definitive Agreement — Nov 17, 2025 Risk: medium
On November 14, 2025, Hyperion DeFi, Inc. entered into a Material Definitive Agreement. The company, formerly known as Eyenovia, Inc., is incorporated in Delawa
Hyperion Defi, Inc. (fka Eyenovia) Files 8-K — Nov 13, 2025 Risk: low
On November 13, 2025, Hyperion Defi, Inc. (formerly Eyenovia, Inc.) filed an 8-K report. The filing indicates a change in the company's name from Eyenovia, Inc.
8-K Filing — Oct 31, 2025
Hyperion Defi, Inc. Files 8-K: Board & Compensation Changes — Oct 2, 2025 Risk: medium
On September 30, 2025, HYPERION DEFI, INC. (formerly EYENOVIA, INC.) filed an 8-K report detailing changes in its board of directors and executive compensation.
Hyperion DeFi Files 8-K: Officer/Director Changes & Financials — Sep 29, 2025 Risk: medium
On September 29, 2025, Hyperion DeFi, Inc. (formerly EyenovIA, Inc.) filed an 8-K report. The filing indicates changes in directors or officers, potential regul
Hyperion DeFi Files 8-K for Material Agreement — Sep 24, 2025 Risk: medium
On September 24, 2025, Hyperion DeFi, Inc. (formerly Eyenovia, Inc.) filed an 8-K report. The filing indicates an entry into a material definitive agreement and
Hyperion DeFi Faces Delisting Notice, Board Changes — Sep 8, 2025 Risk: high
Hyperion DeFi, Inc. (formerly EyenovIA, Inc.) filed an 8-K on September 8, 2025, reporting a change in its listing status. The company received a notice of deli
Hyperion DeFi, Inc. Files 8-K Report — Aug 21, 2025 Risk: medium
On August 18, 2025, Hyperion DeFi, Inc. (formerly Eyenovia, Inc.) filed an 8-K report. The filing indicates a change in the company's name and potentially other
Hyperion Defi, Inc. (fka Eyenovia) Files 8-K — Aug 13, 2025 Risk: low
On August 13, 2025, HYPERION DEFI, INC. filed an 8-K report. The filing indicates a change in the company's name from EYENOVIA, INC. to HYPERION DEFI, INC. on A
Hyperion DeFi, Inc. Reports Board Changes and Fiscal Year Update — Jul 2, 2025 Risk: medium
On June 30, 2025, Hyperion DeFi, Inc. (formerly Eyenovia, Inc.) filed an 8-K report detailing several key events. The company announced changes in its board of
EyEnovia Closes $25M Public Offering — Jun 27, 2025 Risk: medium
On June 25, 2025, EyEnovia, Inc. filed an 8-K report detailing the closing of its previously announced underwritten public offering. The company successfully ra
Eyevia, Inc. Files 8-K: Material Agreement, Equity Sales, Officer Changes — Jun 24, 2025 Risk: medium
On June 17, 2025, Eyevia, Inc. entered into a material definitive agreement, likely related to financing or a significant business transaction. The company also
EYENOVIA, INC. Files 8-K for Material Agreement — Jun 5, 2025 Risk: medium
On May 30, 2025, EYENOVIA, INC. entered into a material definitive agreement. The filing also includes financial statements and exhibits. The company is incorpo
EYENOVIA, INC. Files 8-K on Financials — May 19, 2025 Risk: low
On May 19, 2025, EYENOVIA, INC. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as finan
EYENOVIA, INC. Faces Delisting Concerns — May 2, 2025 Risk: high
On April 29, 2025, EYENOVIA, INC. filed an 8-K report indicating a notice of delisting or failure to satisfy a continued listing rule or standard. The company i
EyEnovIA, Inc. Files 8-K Report — Mar 20, 2025 Risk: low
On March 18, 2025, EyEnovIA, Inc. filed an 8-K report detailing the results of operations and other events. The filing includes financial statements and exhibit
EYENOVIA, INC. Files 8-K Report — Feb 25, 2025 Risk: low
On February 25, 2025, EYENOVIA, INC. filed an 8-K report. The filing indicates "Other Events" as the primary item of information. No specific details regarding
EyEnovia, Inc. Files 8-K for Material Definitive Agreement — Feb 24, 2025 Risk: medium
On February 21, 2025, EyEnovia, Inc. entered into a material definitive agreement, creating a direct financial obligation. The company, incorporated in Delaware
EYENOVIA, INC. Files 8-K Report — Jan 31, 2025 Risk: low
On January 31, 2025, EYENOVIA, INC. filed an 8-K report. The filing primarily concerns other events and financial statements/exhibits, with no specific material
EYENOVIA, INC. Files 8-K Report — Jan 28, 2025 Risk: low
On January 28, 2025, EYENOVIA, INC. filed an 8-K report. The filing primarily concerns financial statements and exhibits, indicating potential updates or disclo
EYENOVIA, INC. Files 8-K on Shareholder Vote Matters — Jan 24, 2025 Risk: medium
On January 21, 2025, EYENOVIA, INC. filed an 8-K report detailing a submission of matters to a vote of its security holders. The filing does not disclose specif
EyEnovIA Files 8-K: Material Agreement, Equity Sales — Jan 16, 2025 Risk: medium
On January 16, 2025, EyEnovIA, Inc. entered into a Material Definitive Agreement. The company also reported on Unregistered Sales of Equity Securities and filed
EyEnovia Closes $34.5M Public Offering — Dec 30, 2024 Risk: medium
On December 30, 2024, EyEnovia, Inc. announced the closing of its previously disclosed underwritten public offering. The company successfully raised approximate
EYENOVIA Faces Nasdaq Delisting Over Bid Price — Dec 13, 2024 Risk: high
On December 12, 2024, EYENOVIA, INC. filed an 8-K report indicating a potential delisting from the Nasdaq Capital Market. The company received a notice from Nas
EyEnovia, Inc. Signs Material Definitive Agreement — Dec 9, 2024 Risk: medium
On December 5, 2024, EyEnovia, Inc. entered into a Material Definitive Agreement. The filing does not specify the other party or the nature of the agreement, bu
EyEnovia, Inc. Files 8-K: Material Definitive Agreement — Nov 26, 2024 Risk: medium
On November 24, 2024, EyEnovia, Inc. entered into a Material Definitive Agreement. The filing also includes Regulation FD Disclosure and Financial Statements an
Eyevia, Inc. Reports Material Agreement and Financial Obligations — Nov 25, 2024 Risk: medium
On November 22, 2024, Eyevia, Inc. entered into a material definitive agreement related to a direct financial obligation. The company also reported on the creat
EyEnovIA, Inc. Files 8-K: Other Events — Nov 20, 2024 Risk: medium
On November 19, 2024, EyEnovIA, Inc. filed an 8-K report. The filing indicates an 'Other Events' category, suggesting a significant, non-routine event has occur
EYENOVIA, INC. Files 8-K on Exit Costs and Other Events — Nov 15, 2024 Risk: medium
On November 15, 2024, EYENOVIA, INC. filed an 8-K report detailing cost associated with exit or disposal activities. The filing also includes other events and f
EYENOVIA, INC. Files 8-K on Financials — Nov 12, 2024 Risk: low
On November 12, 2024, EYENOVIA, INC. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as
EyEnovIA, Inc. Files 8-K for Material Definitive Agreement — Sep 30, 2024 Risk: medium
On September 26, 2024, EyEnovIA, Inc. entered into a Material Definitive Agreement, the details of which are not fully disclosed in this filing. The company, in
EYENOVIA Receives Nasdaq Delisting Warning — Sep 20, 2024 Risk: high
On September 18, 2024, EYENOVIA, INC. filed an 8-K report indicating it received a notification from the Nasdaq Stock Market on September 17, 2024, that it is n
EyEnovia Appoints New CMO, Closes $25M Financing — Sep 3, 2024 Risk: medium
On August 30, 2024, EyEnovia, Inc. filed an 8-K report detailing the departure of Director Michael J. Miller and the appointment of Dr. Arshad Khan as Chief Med
EYENOVIA, INC. Files 8-K Report — Aug 23, 2024 Risk: low
On August 23, 2024, EYENOVIA, INC. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No specifi
EyEnovia Files 8-K: Material Agreement, Financials — Aug 22, 2024 Risk: medium
On August 20, 2024, EyEnovia, Inc. entered into a Material Definitive Agreement. The filing also includes Regulation FD Disclosure and Financial Statements and
EYENOVIA, INC. Files 8-K on Financials — Aug 13, 2024 Risk: low
On August 12, 2024, EYENOVIA, INC. filed an 8-K report detailing its financial results and condition. The filing includes financial statements and exhibits, pro
EYENOVIA, INC. Files 8-K: Other Event — Jul 29, 2024 Risk: medium
On July 26, 2024, EYENOVIA, INC. filed an 8-K report detailing an "Other Event." The filing does not provide specific details about the event itself, but it ind
EYENOVIA Receives Nasdaq Delisting Warning — Jul 5, 2024 Risk: high
On July 2, 2024, EYENOVIA, INC. filed an 8-K report indicating it received a notice from the Nasdaq Stock Market regarding its failure to meet the minimum bid p
EyEnovia, Inc. Files 8-K for Material Definitive Agreement — Jul 1, 2024 Risk: medium
On June 27, 2024, EyEnovia, Inc. entered into a Material Definitive Agreement. The company, incorporated in Delaware with its principal executive offices in New
EYENOVIA, INC. Files 8-K on Security Holder Rights and Voting — Jun 14, 2024 Risk: low
On June 12, 2024, EYENOVIA, INC. filed an 8-K report detailing material modifications to the rights of its security holders and the submission of matters to a v
EYENOVIA, INC. Files 8-K Report — Jun 4, 2024 Risk: low
On June 4, 2024, EYENOVIA, INC. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No specific f
EYENOVIA, INC. Files 8-K Report — May 16, 2024 Risk: low
On May 16, 2024, EYENOVIA, INC. filed an 8-K report. The filing primarily concerns financial statements and exhibits, indicating updates or disclosures related
EYENOVIA, INC. Files 8-K on Financials — May 15, 2024 Risk: low
On May 15, 2024, EYENOVIA, INC. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as finan
EYENOVIA, INC. Files 8-K Report — Apr 10, 2024 Risk: low
On April 9, 2024, EYENOVIA, INC. filed an 8-K report. The filing primarily concerns financial statements and exhibits, with no other specific events detailed in
EyEnovia, Inc. Files 8-K for Material Definitive Agreement — Apr 9, 2024 Risk: medium
On April 8, 2024, EyEnovia, Inc. entered into a Material Definitive Agreement. The company, incorporated in Delaware with its principal executive offices in New
EYENOVIA Raises $30M in Public Offering — Apr 8, 2024 Risk: medium
On April 8, 2024, EYENOVIA, INC. announced the closing of its previously announced underwritten public offering. The company successfully raised approximately $
EYENOVIA, INC. Files 8-K Report — Mar 19, 2024 Risk: low
On March 19, 2024, EYENOVIA, INC. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No specific
EYENOVIA Files 8-K for Rule 425 Communications, Nasdaq Listing Confirmed — Jan 25, 2024
EYENOVIA, INC. filed an 8-K on January 25, 2024, primarily to indicate that it is making written communications pursuant to Rule 425 under the Securities Act. T

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX